From Disclosure to Transparency The Use of Company Payment Data

被引:56
作者
Chimonas, Susan [1 ]
Frosch, Zachary [1 ]
Rothman, David J. [1 ]
机构
[1] Columbia Univ, Coll Phys & Surg, Ctr Med Profess, New York, NY 10032 USA
关键词
CONFLICTS; JOURNALS; INDUSTRY;
D O I
10.1001/archinternmed.2010.341
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: It has become standard practice in medical journals to require authors to disclose their relationships with industry. However, these requirements vary among journals and often lack specificity. As a result, disclosures may not consistently reveal author-industry ties. Methods: We examined the 2007 physician payment information from 5 orthopedic device companies to evaluate the current journal disclosure system. We compared company payment information for recipients of $1 million or more with disclosures in the recipients' journal articles. Payment data were obtained from Biomet, DePuy, Smith & Nephew, Stryker, and Zimmer. Disclosures were obtained in the acknowledgments section, conflict of interest statements, and financial disclosures of recipients' published articles. We also assessed variations in disclosure by authorship position, payment-article relatedness, and journal disclosure policies. Results: Of the 41 individuals who received $1 million or more in 2007, 32 had published articles relating to orthopedics between January 1, 2008, and January 15, 2009. Disclosures of company payments varied considerably. Prominent authorship position and article-payment relatedness were associated with greater disclosure, although nondisclosure rates remained high (46% among first-, sole-, and senior-authored ankles and 50% among articles directly or indirectly related to payments). The accuracy of disclosures did not vary with the strength of journals' disclosure policies. Conclusions: Current journal disclosure practices do not yield complete or consistent information regarding authors' industry ties. Medical journals, along with other medical institutions, should consider new strategies to facilitate accurate and complete transparency. Arch Intern Med. 2011;171(1):81-86. Published online September 13, 2010. doi:10.1001/archinternmed.2010.341
引用
收藏
页码:81 / 86
页数:6
相关论文
共 19 条
[1]  
[Anonymous], UNREVEALED NONDISCLO
[2]  
[Anonymous], Deferred Prosecution Law Legal Definition
[3]   Scope and impact of financial conflicts of interest in biomedical research - A systematic review [J].
Bekelman, JE ;
Li, Y ;
Gross, CP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (04) :454-465
[4]   Conflict of interest disclosure policies and practices in peer-reviewed biomedical journals [J].
Cooper, Richelle J. ;
Gupta, Malkeet ;
Wilkes, Michael S. ;
Hoffman, Jerome R. .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2006, 21 (12) :1248-1252
[5]  
Drazen JM, 2010, ANN INTERN MED, V152, P125, DOI [10.7326/0003-4819-152-2-200901190-00160, 10.7326/0000605-200901190-00160]
[6]  
Eli Lilly and Co, LILL SET BEC 1 PHARM
[7]  
Goozner M., 2008, COMMON STANDARD CONF
[8]  
Institute of Medicine, 2009, DETAILED RULES COMMO
[9]  
*INT COMM MED J ED, UN REQ MAN SUBM BIOM
[10]  
International Committee of Medical Journal Editors, ICMJE FORM DISCL POT